Trxade Group (MEDS)
(Delayed Data from NSDQ)
$6.45 USD
-0.05 (-0.77%)
Updated Apr 24, 2024 03:59 PM ET
After-Market: $6.69 +0.24 (3.72%) 7:58 PM ET
NA Value NA Growth NA Momentum NA VGM
View All Zacks #1 Ranked Stocks
Brokerage Reports
0 items in cart
TRxADE HEALTH, Inc. [MEDS]
Reports for Purchase
Showing records 1 - 17 ( 17 total )
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Discontinuing coverage due to termination of services
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 5.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Optimized Entry and Exit Levels for MEDS 112223
Provider: Stock Traders Daily
Analyst: Research Department
Price: 12.50
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
We are removing are rating and price target due to merger related activities
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 12.50
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating and 12-month price target of $0.45 per share.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 25.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating but reducing our 12-month price target to $0.45 per share.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 25.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating but reducing our 12-month price target to $1.75 per share from $3.00 per share due to reductions in our 2023
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 25.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating but reducing our 12-month price target to $3.00 per share from $3.75 per share due to a reduced 2023 sales per share
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 25.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating but reducing our 12-month price target to $3.75 per share from $6.25 per share
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 25.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating but reducing our 12-month price target to $6.25 per share from $7.00 per share based on our 2023 revenue per share forecast.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 25.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating and 12-month price target of $7.00 per share
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 25.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Price: 25.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating but reducing our 12-month price target to $7.00 per share
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 50.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating but reducing our 12-month price target to $7.25 from $9.50 per share due to a reduced 2022 EPS forecast
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 50.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating and 12-month price target of $9.50 per share.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 50.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating but decreasing our 12-month price target to $9.50 per share from $10.50 per share
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 50.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Maintaining Speculative Buy rating and increasing our 12-month price target to $10.50 per share from $9.50 per share
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 50.00
Company: TRxADE HEALTH, Inc.
Industry: Internet - Commerce
Initiating with a Speculative Buy rating and 12-month price target of $9.50 per share based on our 2021 EPS forecast.
Provider: Taglich Brothers, Inc.
Analyst: HALPERN H
Price: 50.00
|
|